Under construction – not a live service
Sign in
CompletedNo phase

Thailand HDV Cohort

Key facts

Who runs it
The HIV Netherlands Australia Thailand Research Collaboration
Where
Thailand4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
3,296 people enrolled
Started
30 Jan 2023
Ended
1 May 2025
Type of study
Observational
Record updated
17 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Male or female, aged 18 years and older
  • Chronically-infected with HBV, as defined by:; Positive Hepatitis B surface antigen HBsAg) or HBV DNA result with a subsequent positive HBsAg or HBV DNA result at least 6 months after first positive result
  • Provide signed and dated informed consent form

Who cannot take part

  • Non chronic HBV

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

There is very limited data of HDV in Thailand. As both HDV and HIV can accelerate the HBV course and increased the risk of death, particularly, among those with low CD4 cells/count, therefore, HDV burden in this special population is unmet need. Therefore, this study plans to perform a nationwide survey of the prevalence and predictor of HDV among people uses drugs (PWID) with and without HIV, HBV/HIV (MSM vs non MSM), HBV related cirrhosis. Findinds from this study will provide the scientific community to understand how important HDV is among HBV patients, this could be used to develop strategies for HDV screening and treatment

The group in the trial

  • HDV cohort

    Chronic Hepatitis B (HBsAg+) with cirrhosis (APRI \>1.5, FIB-4 \> 3.25, Fibroscan \> 12.5, imaging), PWID with HBV, HIV/HBV, HBV/HCV, aged 18 years and older

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prevalence, Risk Factor and Clinical Significance of Hepatitis D Virus Infection Among Targeted High Risk Population in Thailand: Nationwide Survey 2022-2024
Record updated
17 September 2026